Back to News
May 18, 2026 4:00 PM

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) and is expected to push the life-science tools and diagnostics company to improve its lagging share performance.

Bio-Rad develops instruments and software used by hospitals, blood banks, and medical laboratories.

However, the company's founding family retains majority voting control, potentially complicating efforts by activists to drive strategic or operational changes, the Wall Street Journal reported on Sunday.

Read Also:

Qiagen Explores Possible Sale After New Buyer Talks: Report

Sartorius Investment Draws Attention

Elliott is also reportedly a major investor in Sartorius, the German pharmaceutical and laboratory equipment supplier in which Bio-Rad holds a strategic investment.

Bio-Rad's stake in Sartorius ...